Dr. Mobin Paul | Haadimedics.com

Doctor: Dr. Mobin Paul

Dr. Mobin Paul Send Enquiry Chat

Get response within 24hrs

HEMETOLOGIST | Kochi | India
MBBS GOVT MEDICAL COLLEGE THRISSUR MD(GENERAL MEDICINE) ST.JOHNS MEDICAL COLLEGE BANGALORE DM(CLINICAL HEMATOLOGY) CMC VELLORE | Years of Experiences

Aster Medcity Kochi

Dr. Mobin Paul as a distinguished Senior Consultant in the Department of Clinical Hematology & Hemato Oncology at Rajagiri Hospital, offers a wealth of knowledge that has been refined over years of devoted service.
Dr. Paul was steeped in the culture of excellence and innovation that defines one of India’s premier medical schools, having received his foundation in medicine from the esteemed Christian Medical College (CMC), Vellore.
Dr. Paul has shown an unwavering dedication to the comprehensive management of both benign and malignant hematological disorders throughout the course of his illustrious career.
He can handle complexity with grace and accuracy because of his extensive experience in a variety of situations.
Dr. Paul is well-regarded by both patients and colleagues for his skill in treating both common hematological illnesses and uncommon and difficult cases.
Dr. Paul is especially knowledgeable in the complex field of acute leukemia, having become a recognized expert in this field.
Dr. Paul’s skillful diagnostic acumen and sophisticated comprehension of the pathophysiology of leukemia allow him to effectively customize treatment plans to meet the needs of each patient.
He strikes a careful mix between aggressive chemotherapy regimens and supportive care techniques, always looking to maximize benefits and reduce side effects.
Dr. Paul is well-known for his expertise in bone marrow transplantation (BMT), a vital component of contemporary hemato-oncology, in addition to his command of leukemia management.
Dr. Paul’s experience with BMT covers the full spectrum of care, from careful patient selection and regimen design to post-transplant monitoring and managing graft-versus-host disease.
He stresses the importance of psychosocial support for patients and their families during this difficult journey, in addition to the technical aspects of transplantation, as part of his holistic approach

MBBS

GOVT MEDICAL COLLEGE THRISSUR

MD(GENERAL MEDICINE)

ST.JOHNS MEDICAL COLLEGE BANGALORE

DM(CLINICAL HEMATOLOGY)

CMC VELLORE

Chemotherapy for various types of leukemia (acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia)
Stem cell transplantation (autologous or allogeneic) for hematologic malignancies
Targeted therapy for specific genetic mutations in hematologic cancers (e.g., imatinib for chronic myeloid leukemia)
Radiation therapy for lymphomas (Hodgkin lymphoma, non-Hodgkin lymphoma)
Immunotherapy (e.g., monoclonal antibodies, CAR-T cell therapy) for hematologic cancers
Blood transfusions for anemia management in patients with leukemia or lymphoma
Treatment for myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, myelofibrosis)
Management of bleeding disorders (hemophilia, von Willebrand disease)
Iron chelation therapy for patients with iron overload due to repeated blood transfusions
Supportive care for patients undergoing chemotherapy (antiemetics, growth factors)
Palliative care for patients with advanced hematologic malignancies
Treatment for thrombotic disorders (deep vein thrombosis, pulmonary embolism)
Management of myelodysplastic syndromes (MDS)
Genetic counseling and testing for hereditary hematologic conditions
Treatment for bone marrow failure syndromes (aplastic anemia, myelodysplastic syndromes)
Management of lymphoproliferative disorders (multiple myeloma, Waldenström macroglobulinemia)
Anticoagulant therapy for venous thromboembolism prevention and treatment
Supportive care for patients with sickle cell disease (pain management, hydroxyurea therapy)
Treatment for thrombocytopenia (immune thrombocytopenic purpura, thrombotic thrombocytopenic purpura)
Investigational therapies and clinical trials for novel treatments in hematology and hematologic oncology.